• Built-From-Scratch Screening Device Takes Aim at Ovarian Cancer

    Apr 22 | Diagnostics World | It is notoriously difficult to detect ovarian cancer early, particularly aggressive high-grade serous types that often originate as precursor lesions in the fallopian tubes. The cancer quietly spreads at a microscopic level within the abdomen, defying discovery until symptoms emerge in advanced stages of the disease when it becomes hard to treat and difficult to cure. More

  • Walking Patterns May Help Differentiate Between Parkinson’s Disease and Dementia with Lewy Bodies

    Apr 17 | Diagnostics World | Early dementia with Lewy bodies (DLB) and early Parkinson’s disease share several symptoms and are often misdiagnosed in early stages. It is critical to accurately distinguish the two diseases because of their contrasting disease paths. Fortunately, walking behaviors may be early diagnostic markers for neurodegeneration. More

  • Children’s Hospital of Philadelphia and Labcorp Collaborate for Pediatric Diagnosis

    Apr 16 | Diagnostics World | Labcorp and the Children’s Hospital of Philadelphia (CHOP) announced this week that they will be entering a collaboration to advance the discovery and development of specialized pediatric diagnostics, as well as expand access to advanced diagnostic testing for children and families across the nation. More

  • Study Links Executive Functioning to Physical Activity in Older Adults

    Apr 14 | Diagnostics World | Researchers in Belgium compared cognition to movement data in healthy adults looking for links that might predict cognitive decline later in life. The study is part of the PASOCA-project (how Physical Activity and Sleep relate to Optimal Cognitive Ageing), a two-year longitudinal, observational study examining 24-hour movement behaviors and cognitive function in cognitively healthy adults aged 55 and older residing in Flanders, Belgium. More

  • Using Genomics to Tease Apart Racial Disparities in Breast Cancer Outcomes

    Apr 10 | Diagnostics World | New research released in pre-print from npj Breast Cancer digs deeper into the racial disparities of breast cancer and how the MammaPrint and BluePrint genomic tests from Agendia handle the differences. More

  • From Fingertip to Mainstream: Babson Diagnostics Bets Its Decade of Science Is Ready for Prime Time

    Apr 09 | Diagnostics World | When Web Golinkin joined Babson Diagnostics as an advisor in mid-2024, he did what experienced healthcare executives do: he listened, watched, and formed a thesis. After eight months advising, a brief stint as president and chief commercial officer, and now one month into the CEO role, his thesis has hardened into conviction. More

  • The Future of Blood Testing Lies in Understanding the Whole Body

    Apr 03 | Diagnostics World | For decades, blood testing innovation has focused on improving patient testing for earlier and faster intervention. Advances in sequencing, automation, and molecular testing have dramatically improved our ability to biologically monitor patients. But as powerful as these technologies have become, they often still operate within a limited framework: they look for a biomarker panel that constitutes a single signal tied to a single disease. More

  • Handheld AI-Powered Eye Scanner Could Reach More Patients

    Apr 02 | Diagnostics World | Research out of Tohoku University in Sendai, Japan, provides a model for easily assessing front of the eye health outside of hospitals. The research team envisions employing the portable AI-powered scanning slit-light device in remote eye-screening camps, elderly-care facilities, pharmacies, or even train stations to make ophthalmic care more accessible, so patients can be assessed any place and any time. More

  • Roche ApoE4 Blood Test

    Apr 01 | Diagnostics World | Roche has received CE Mark approval for its Elecsys Apolipoprotein E4 biomarker test – the first in-vitro diagnostic (IVD) immunoassay to identify the presence of the ApoE4 gene variant in the bloodstream. More

  • Follow the Money: Precision Genetic Drugs, Engineering Synthetic Macrocyclic Peptides, More

    Mar 25 | Diagnostics World | BreezeBio, formerly known as GenEdit, advances their NanoGalaxy delivery platform; Unnatural Products develops their proprietary drug discovery platform; and more. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more